Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Lowered to $115 at Piper Sandler After a 'Disappointing Q1'

April 17, 2026 9:48 AM
Piper Sandler analyst Adam Maeder lowered the price target on Abbott Labs (NYSE: ABT) to $115.00 (from $135.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change